08:00 , Nov 4, 2013 |  BC Week In Review  |  Company News

Dara BioSciences, Mission Pharmacal sales and marketing update

Mission granted Dara exclusive commercialization rights in the U.S. to three marketed drugs - Ferralet for anemia, Binosto alendronate for osteoporosis and Aquoral for xerostomia. Additionally, Dara entered a deal with Mission's Alamo...
08:00 , Feb 6, 2012 |  BC Week In Review  |  Company News

Apricus Biosciences, PediatRx Inc. deal

The companies signed a non-binding term sheet for Apricus to acquire PediatRx for about $4 million in stock and the assumption of $675,000 of PediatRx's debt. The deal is subject to approval by both companies...
07:00 , Sep 19, 2011 |  BC Week In Review  |  Company News

Bi-Coastal Pharmaceutical Corp., PediatRx Inc. sales and marketing update

Bi-Coastal granted PediatRx co-promotion rights to Aquoral oxidized glycerol triesters in the U.S. The oral spray is approved to treat xerostomia (dry mouth). Bi-Coastal acquired exclusive rights to market Aquoral in the U.S. for the...
07:00 , Sep 20, 2010 |  BC Week In Review  |  Company News

IS Pharma sales and marketing update

IS Pharma launched Aquoral oxidized glycerol triesters in the U.K. to lubricate and protect the oral mucosa in xerostomia (dry mouth). The wholesale acquisition cost (WAC) is about £10 ($15.47) for a 40 mL oral...
08:00 , Jan 5, 2009 |  BC Week In Review  |  Company News

Bi-Coastal Pharmaceutical Corp. sales and marketing update

Bi-Coastal acquired exclusive rights to market Aquoral oxidized glycerol triesters in the U.S. to treat xerostomia (dry mouth). The product was marketed by Auriga Laboratories Inc., which dissolved. Financial terms were not disclosed....
08:00 , Mar 5, 2007 |  BC Week In Review  |  Company News

Auriga sales and marketing update

ARGA launched Aquoral oxidized glycerol triesters, to treat xerostomia (dry mouth) in the U.S. The lipid-based solution's wholesale acquisition cost is $70 for a 1.4 fluid oz. bottle, which is a two-month supply. Auriga...
08:00 , Dec 18, 2006 |  BC Week In Review  |  Company News

Auriga sales and marketing update

ARGA increased its U.S. sales force by 47 to 56 reps. The company's marketed drugs include the Extendryl line of cough and cold products, the Levall line of common cold products and Aquoral for...